Key statistics
As of last trade, Pacira Biosciences Inc (82P:STU) traded at 16.10, 57.84% above the 52 week low of 10.20 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.10 |
---|---|
High | 16.20 |
Low | 16.10 |
Bid | 15.90 |
Offer | 16.30 |
Previous close | 16.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 46.17m |
Free float | 45.16m |
P/E (TTM) | -- |
Market cap | 796.03m USD |
EPS (TTM) | -2.15 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
- Pacira BioSciences Reports Third Quarter 2024 Financial Results
- Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings
- Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024
- Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
- Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
- Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
- Pacira BioSciences Reports Second Quarter 2024 Financial Results
- Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
More ▼